United Therapeutics (UTHR) News Today $317.34 -2.52 (-0.79%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period KLP Kapitalforvaltning AS Invests $15.28 Million in United Therapeutics Co. (NASDAQ:UTHR)KLP Kapitalforvaltning AS acquired a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 43,300 shares of the biotechnology company's stock, valued at approximately $March 25 at 5:19 AM | marketbeat.comTeacher Retirement System of Texas Acquires 1,626 Shares of United Therapeutics Co. (NASDAQ:UTHR)Teacher Retirement System of Texas boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 14.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,945 shares of the biotechnology comMarch 25 at 4:12 AM | marketbeat.com1,287 Shares in United Therapeutics Co. (NASDAQ:UTHR) Bought by AXQ Capital LPAXQ Capital LP purchased a new stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,287 shares of the biotechnology company's stock, valued at apprMarch 24 at 5:42 AM | marketbeat.comSummit Global Investments Has $12.73 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)Summit Global Investments trimmed its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 27.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,081 shares of the biotechnology company's stMarch 23 at 5:49 AM | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Stock Position Trimmed by Natixis Advisors LLCNatixis Advisors LLC cut its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 19.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,735 shares of the biotechnology company's stock after selMarch 23 at 3:54 AM | marketbeat.comInvesting Action Plan: Anduril Industries, United Therapeutics, Barstool In MiamiMarch 23 at 12:09 AM | investors.comHarvest Fund Management Co. Ltd Purchases 2,021 Shares of United Therapeutics Co. (NASDAQ:UTHR)Harvest Fund Management Co. Ltd grew its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 300.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,693 shares of the biotechnology company's stock after buying an addMarch 22 at 5:02 AM | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Corient Private Wealth LLCCorient Private Wealth LLC cut its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 9.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,689 shares of theMarch 22 at 4:10 AM | marketbeat.comBuy Recommendation for United Therapeutics: Undervalued Potential in IPF Treatment with TyvasoMarch 21, 2025 | tipranks.comGenerali Asset Management SPA SGR Invests $3.01 Million in United Therapeutics Co. (NASDAQ:UTHR)Generali Asset Management SPA SGR bought a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 8,524 shares of the biotechnology company's stock, valued at approximateMarch 21, 2025 | marketbeat.comZacks Research Issues Pessimistic Outlook for UTHR EarningsMarch 21, 2025 | americanbankingnews.comVinva Investment Management Ltd Sells 10,085 Shares of United Therapeutics Co. (NASDAQ:UTHR)Vinva Investment Management Ltd cut its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 34.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,524 shares of the biotechnologyMarch 20, 2025 | marketbeat.comZacks Research Brokers Lower Earnings Estimates for UTHRUnited Therapeutics Co. (NASDAQ:UTHR - Free Report) - Investment analysts at Zacks Research lowered their Q1 2025 EPS estimates for United Therapeutics in a research note issued on Monday, March 17th. Zacks Research analyst R. Department now forecasts that the biotechnology company will earn $6.3March 20, 2025 | marketbeat.comThrivent Financial for Lutherans Acquires 189,967 Shares of United Therapeutics Co. (NASDAQ:UTHR)Thrivent Financial for Lutherans lifted its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 1,325.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 204,299 shares of the biotechnology company's stock after purchasMarch 20, 2025 | marketbeat.comUnited Therapeutics price target lowered to $314 from $328 at BofAMarch 19, 2025 | markets.businessinsider.comShort Interest in United Therapeutics Co. (NASDAQ:UTHR) Increases By 18.8%United Therapeutics Co. (NASDAQ:UTHR - Get Free Report) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 2,460,000 shares, a growth of 18.8% from the February 13th total of 2,070,000 shares. Approximately 5.6% of the company's stock are short sold. Based on an average daily volume of 403,500 shares, the short-interest ratio is presently 6.1 days.March 19, 2025 | marketbeat.com51,744 Shares in United Therapeutics Co. (NASDAQ:UTHR) Bought by Raymond James Financial Inc.Raymond James Financial Inc. bought a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 51,744 shares of the biotechnology company's stockMarch 18, 2025 | marketbeat.comBrandes Investment Partners LP Has $524,000 Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Brandes Investment Partners LP lowered its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 87.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,484 shares of the biotechnology company's stock after selling 10,210March 17, 2025 | marketbeat.comSwiss National Bank Lowers Position in United Therapeutics Co. (NASDAQ:UTHR)Swiss National Bank lessened its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 4.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 119,455 shares of the biotechnology company's stock after selling 5,600 shares duringMarch 17, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)Connor Clark & Lunn Investment Management Ltd. grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 32.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,5March 17, 2025 | marketbeat.comGlobeflex Capital L P Trims Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Globeflex Capital L P cut its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 8.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 54,858 shares of the biotechnology company's stocMarch 16, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Tredje AP fondenTredje AP fonden decreased its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 50.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,680 shares of the biotechnology company'sMarch 16, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Stake Lessened by Skandinaviska Enskilda Banken AB publSkandinaviska Enskilda Banken AB publ lessened its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 11.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 84,005 shares of the biotechnologyMarch 15, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by Erste Asset Management GmbHErste Asset Management GmbH raised its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 47,136 shaMarch 15, 2025 | marketbeat.comAchmea Investment Management B.V. Has $12.97 Million Position in United Therapeutics Co. (NASDAQ:UTHR)Achmea Investment Management B.V. raised its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 52.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,746 shares of the biotechnology compMarch 15, 2025 | marketbeat.comProficio Capital Partners LLC Invests $22.66 Million in United Therapeutics Co. (NASDAQ:UTHR)Proficio Capital Partners LLC bought a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 64,217 shares of the bioteMarch 15, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Receives Consensus Recommendation of "Moderate Buy" from AnalystsUnited Therapeutics Co. (NASDAQ:UTHR - Get Free Report) has received a consensus rating of "Moderate Buy" from the twelve ratings firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendaMarch 15, 2025 | marketbeat.comIs United Therapeutics Corporation (UTHR) the Best Healthcare Stock For Long-Term Investment?March 14, 2025 | insidermonkey.comZurcher Kantonalbank Zurich Cantonalbank Has $11.46 Million Position in United Therapeutics Co. (NASDAQ:UTHR)Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 11.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,464 sharesMarch 13, 2025 | marketbeat.comAmundi Has $42.97 Million Stake in United Therapeutics Co. (NASDAQ:UTHR)Amundi raised its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 79.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 117,205 shares of the biotechnology company's stock afterMarch 13, 2025 | marketbeat.comWealthfront Advisers LLC Acquires 18,313,424 Shares of United Therapeutics Co. (NASDAQ:UTHR)Wealthfront Advisers LLC raised its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 2,090,573.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,314,300 sMarch 12, 2025 | marketbeat.comTracking Renaissance Technologies 13F Portfolio - Q4 2024 UpdateMarch 11, 2025 | seekingalpha.comUnited Therapeutics Co. (NASDAQ:UTHR) Stake Raised by AlphaQuest LLCAlphaQuest LLC raised its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 85.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,312 shares of the biotechnology company'March 11, 2025 | marketbeat.com918 Shares in United Therapeutics Co. (NASDAQ:UTHR) Acquired by Callan Family Office LLCCallan Family Office LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 918 shares of the biotechnology company's stock, valued at approxiMarch 11, 2025 | marketbeat.comRuffer LLP Invests $4.04 Million in United Therapeutics Co. (NASDAQ:UTHR)Ruffer LLP bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 11,449 shares of the biotechnology company's stock, valued at approximately $4,0March 10, 2025 | marketbeat.comEdgestream Partners L.P. Boosts Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Edgestream Partners L.P. boosted its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 61.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,117 shares of the biotechnology company's stock aftMarch 10, 2025 | marketbeat.comAshton Thomas Private Wealth LLC Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR)Ashton Thomas Private Wealth LLC acquired a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,820 shares of the biotechnology company's stock, valued at aMarch 10, 2025 | marketbeat.comAndra AP fonden Purchases 5,500 Shares of United Therapeutics Co. (NASDAQ:UTHR)Andra AP fonden raised its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 9.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 66,600 shares of the biotechnology company's stock after purchaMarch 8, 2025 | marketbeat.comCandriam S.C.A. Grows Position in United Therapeutics Co. (NASDAQ:UTHR)Candriam S.C.A. grew its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 11.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 74,607 shares of the biotechnology company's stock afMarch 7, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by Victory Capital Management Inc.Victory Capital Management Inc. lifted its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 3.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 193,408 shares of the biotechnology companyMarch 7, 2025 | marketbeat.comSeizert Capital Partners LLC Acquires 1,312 Shares of United Therapeutics Co. (NASDAQ:UTHR)Seizert Capital Partners LLC boosted its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 3.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,218 shares of the biotechnoMarch 5, 2025 | marketbeat.comAssetmark Inc. Boosts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)Assetmark Inc. grew its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 2.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 429,160 shares of the biotechnology company's stock after buying an additionalMarch 5, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Stock Holdings Lifted by Fisher Asset Management LLCFisher Asset Management LLC lifted its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 159.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,339 shares of the biMarch 5, 2025 | marketbeat.comUnited Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025March 4, 2025 | finance.yahoo.comWestover Capital Advisors LLC Invests $679,000 in United Therapeutics Co. (NASDAQ:UTHR)Westover Capital Advisors LLC purchased a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,925 shares of the biotechnology company's stock, vaMarch 4, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Oppenheimer & Co. Inc.Oppenheimer & Co. Inc. decreased its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 25.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,667 shares of the biotechnology company's stock afterMarch 4, 2025 | marketbeat.comLGT Fund Management Co Ltd. Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR)LGT Fund Management Co Ltd. acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,650 shares of the biotechnology company's stockMarch 3, 2025 | marketbeat.comQ2 EPS Estimate for United Therapeutics Lowered by AnalystUnited Therapeutics Co. (NASDAQ:UTHR - Free Report) - Analysts at Leerink Partnrs lowered their Q2 2025 earnings per share (EPS) estimates for United Therapeutics in a research report issued to clients and investors on Thursday, February 27th. Leerink Partnrs analyst R. Ruiz now forecasts that thMarch 3, 2025 | marketbeat.comQ1 Earnings Forecast for UTHR Issued By HC WainwrightUnited Therapeutics Co. (NASDAQ:UTHR - Free Report) - Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of United Therapeutics in a research note issued on Thursday, February 27th. HC Wainwright analyst A. Fein forecasts that the biotechnologyMarch 3, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Poplar Forest Capital LLCPoplar Forest Capital LLC reduced its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 45.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 59,875 shares of the biotechnology company's stock after selling 50,244 shares during the peMarch 2, 2025 | marketbeat.com Remove Ads Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address UTHR Media Mentions By Week UTHR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼1.060.63▲Average Medical News Sentiment UTHR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼2012▲UTHR Articles Average Week Remove Ads Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News BIIB News BMRN News INCY News NBIX News EXEL News EXAS News RGEN News HALO News MDGL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTHR Stock Free UTHR Stock Alerts